Patent details

EP2574168 Title: TOPICAL FORMULATION FOR A JAK INHIBITOR

Basic Information

Publication number:
EP2574168
PCT Application Number:
PCT/US/2011/037291
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP117241042
PCT Publication Number:
WO/2011/146808
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TOPICAL FORMULATION FOR A JAK INHIBITOR
French Title of Invention:
FORMULATION TOPIQUE POUR INHIBITEUR DE JAK
German Title of Invention:
TOPISCHE FORMULIERUNG FÜR EINEN JAK-HEMMER
SPC Number:

Dates

Filing date:
20/05/2011
Grant date:
20/04/2016
EP Publication Date:
20/04/2016
PCT Publication Date:
24/11/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/04/2013
EP B1 Publication Date:
20/04/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
20/05/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/05/2011
 
 

Name:
Incyte Holdings Corporation
Address:
1801 Augustine Cut-Off, Wilmington, DE 19803, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
08/06/2016
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
SHAH Bhavesh
Address:
United States (US)

2

Name:
YELESWARAM Krishnaswamy
Address:
United States (US)

3

Name:
PARIKH Bhavnish
Address:
United States (US)

Priority

Priority Number:
347132 P
Priority Date:
21/05/2010
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/107;

Annual Fees

Annual Fee Due Date:
02/06/2025
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/05/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages